MC Plus Material – 15_Overview of the FY2026 Medical Fee Revision 15. Appropriate Evaluation of Medical Technologies Page 44 – Center for Health Policy Information

News Highlights

According to “MC Plus Material – 15_Overview of the FY2026 Medical Fee Revision” published by the Center for Health Policy Information, the appropriate evaluation of medical technologies will be a focal point in the FY2026 medical fee revision. The importance of medium- to long-term management and succession strategies, considering this revision cycle, is increasing. Specifically, participation in groups that can leverage economies of scale and utilizing tax benefits by transitioning to specific medical corporations or social medical corporations are highlighted as key issues in M&A and business succession for medical institutions.

Perspective from M&A Medical Editorial Department

This document, focusing on the “Appropriate Evaluation of Medical Technologies” within the overview of the FY2026 medical fee revision, should be viewed by medical institution executives not merely as a response to fee revisions, but as a signal to reconstruct their business succession strategies. Particularly, as revision cycles shorten, it is becoming increasingly difficult for individual medical institutions to independently cope with the burden of capital investment and the pressure of maintaining facility standards. For instance, introducing and maintaining advanced medical technologies requires substantial investment, yet the risk of evaluation changes due to medical fee revisions always exists. In such circumstances, grouping multiple medical institutions to cooperate and integrate, thereby enjoying economies of scale, can not only stabilize management but also serve as a practical solution to the issue of lack of successors. Furthermore, considering tax schemes with a view to transitioning to specific medical corporations or social medical corporations is a crucial strategy for reducing tax burdens during business succession and achieving a smooth handover. This revision underscores the necessity for more strategic M&A and business succession for the “survival” and “development” of medical institutions.

Issues Highlighted by This News

• The “Appropriate Evaluation of Medical Technologies” in the FY2026 revision prompts a reconsideration of the balance between technological investment and profitability.
• Maintaining facility standards and dispersing capital investment burdens through economies of scale will be drivers for group M&A.
• Utilizing tax schemes with a view to transitioning to specific medical corporations and social medical corporations holds the key to business succession.
• Early formulation of medium- to long-term management and succession strategies, considering the medical fee revision cycle, is essential.

Practical Questions Arising from This News

• If the evaluation of medical technologies changes, how should the investment recovery plan for currently introduced high-cost medical equipment be revised?
• By grouping, what specific facility standards can be maintained and what capital investment burdens can be dispersed?
• What impact will transitioning to a specific medical corporation or social medical corporation have on the current governance and business operations of the medical corporation?

If You Feel “Should I Consult Too?”

Are you unsure whether to consider concrete solutions for your institution’s risks in revising medical technology evaluations, capital investment plans, and management challenges such as the lack of successors, in light of the trends in the FY2026 medical fee revision? If you are interested in leveraging group formation or tax schemes to benefit from economies of scale for future management stability and smooth business succession, it may be a good time to consider consulting with experts.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a certified M&A support institution by the Small and Medium Enterprise Agency, with a complete success fee system. Consultations are handled with strict confidentiality. Free consultation here